Biologics Discovery Capabilities
Curia’s Biologics Discovery Capabilities overview highlights its fully integrated, end‑to‑end platform supporting antibody and biologics discovery through development and manufacturing. With more than 200 successful antibody discovery campaigns and numerous biologics advanced into clinical evaluation, Curia positions itself as a comprehensive partner for biopharmaceutical programs.
Testimonials emphasize Curia’s scientific partnership and high‑quality antibody outputs. The document concludes with an overview of Curia as a global CDMO with 20+ facilities and 3,000+ staff supporting programs from discovery through commercialization.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.